ABBOTT LABORATORIES

Abbott Laboratories is an Illinois corporation, incorporated in 1900, whose principal business involves the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. On November 19, 2025, Abbott entered into a definitive agreement to acquire Exact Sciences Corporation, which is expected to enable Abbott to enter the cancer diagnostics market. This acquisition is subject to customary closing conditions, including shareholder approval and regulatory clearances. Abbott operates through four reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment includes a broad line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. These products are generally sold directly to wholesalers, distributors, government agencies, healthcare facilities, pharmacies, and independent retailers from Abbott-owned distribution centers or public warehouses. Some products are co-marketed, co-promoted, or licensed from other companies. Key products in this segment's therapeutic portfolios include: - Gastroenterology products: Creon™ for pancreatic exocrine insufficiency; Duspatal™ and Dicetel™ for irritable bowel syndrome or biliary spasm; Heptral™, Transmetil™, and Samyr™ for intrahepatic cholestasis or depressive symptoms; and Duphalac™ for colon rhythm regulation. - Women's health products: Duphaston™ for gynecological disorders; and Femoston™ for postmenopausal hormone replacement therapy. - Cardiovascular and metabolic products: Lipanthyl™ and TriCor™ for dyslipidemia and diabetic retinopathy; Omacor™ for hypertriglyceridemia; Physiotens™ for hypertension; and Synthroid™ for hypothyroidism. - Pain and central nervous system products: Serc™ for Ménière's disease and vestibular vertigo; Brufen™ for pain, fever, and inflammation; and Sevedol™ for severe migraines. - Respiratory drugs and vaccines: including the anti-infective clarithromycin.